Lymphoma, Large B-Cell, Diffuse (DLBCL)

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse (DLBCL). Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse (DLBCL) trial results

Recruiting

NCT06528301

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +19 more
Locations: City of Hope Duarte, California, United States

The David and Etta Jonas Center for Cellular Therapy Chicago, Illinois, United States

Washington University School of Medicine/Siteman Cancer Center St Louis, Missouri, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

Not Yet Recruiting

NCT07476378

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Disease Attributes, +22 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Langfang, Hebei, China

Active, Not Recruiting

NCT05406401

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: BC Cancer Victoria-Clinical Trials Unit ( Site 0105) Victoria, British Columbia, Canada

William Osler Health System ( Site 0106) Toronto, Ontario, Canada

Hopital du Sacre-Coeur de Montreal ( Site 0108) Montreal, Quebec, Canada

Hadassah Medical Center ( Site 0401) Jerusalem, Israel

View all 22 locations